Skip to main content

Table 3 Baseline measurements of participants who completed at least one dietary period reported by diet sequence

From: Diet intervention improves cardiovascular profile in patients with rheumatoid arthritis: results from the randomized controlled cross-over trial ADIRA

 

Intervention-Control

n = 25

Median (IQR)

Control-Intervention

n = 22

Median (IQR)

All

n = 47

Median (IQR)

Age (years)

62.8 (59.3, 72.4)

64.3 (47.8, 72.4)

62.8 (53.9, 70.8)

Weight (kg)

75.5 (65.6, 83.4)

78 (70.6, 83.4)

77.8 (66.9, 85.4)

BMI (kg/m2)

26.9 (23.5, 30.8)

25.9 (24.1, 30.8)

26.6 (24, 31.8)

Waist (cm)

92 (81.5, 98.3)

92.5 (83.8, 98.3)

92 (83, 100)

Hip (cm)

107 (98.5, 109.5)

105.5 (96.8, 109.5)

106 (98, 112)

SBP (mmHg)

130 (121, 146.5)

140 (126.5, 146.5)

135 (125, 140)

DBP (mmHg)

80 (74.5, 89)

80 (70, 89)

80 (72, 89)

DAS28-ESR

3.8 (3.1, 4.6)

3.3 (2.9, 4.6)

3.7 (3, 4.6)

ESR (mm)

20 (11.5, 25.3)

19.5 (8.8, 25.3)

20 (11, 26)

CRP (mg/L)

3 (1, 6)

2.5 (1, 6)

3 (1, 6)

LDL cholesterol (mmol/L)

3.4 (2.6, 4.3)

3.3 (3, 4.3)

3.3 (2.8, 4.2)

HDL cholesterol (mmol/L)

1.7 (1.5, 2.2)

1.5 (1.3, 2.2)

1.6 (1.3, 2)

Triglycerides (mmol/L)

1.1 (1, 1.6)

1.1 (0.7, 1.6)

1.1 (0.8, 1.6)

Total cholesterol (mmol/L)

5.4 (4.6, 6)

5.6 (4.6, 6)

5.5 (4.6, 6)

Apo-B100 (mg/dL)a

82.6 (69.7, 90.2)

82.8 (67.7, 104)

82.7 (69.7, 94.7)

Apo-A1 (mg/dL)a

141 (135, 156)

139 (121, 162)

140 (124, 157)

Apo-B100/Apo-A1a

0.57 (0.47, 0.65)

0.59 (0.50, 0.76)

0.57 (0.49, 0.71)

  1. Values presented as median (Interquartile range; IQR). BMI Body Mass Index, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, DAS28-ESR Disease Activity Score Erythrocyte Sedimentation rate, ESR Erythrocyte Sedimentation Rate, LDL Low Density Lipoprotein, HDL High Density Lipoprotein, Apo-B100 Apolipoprotein B100, Apo-A1 Apolipoprotein A1
  2. aIntervention-control, n = 23; Control-intervention, n = 21; All, n = 44